[Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate]
- PMID: 930544
[Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate]
Abstract
The absorption, blood level and renal excretion of chlorphenoxyisobutyric acid (clofibric acid) were examined following oral dosage of the magnesium salt (magnesium clofibrate) in a combination preparation containing meso-inositol hexanicotinate. Absorption of clofibric acid was found to be identical with that obtained with ethyl-alpha-p-chlorphenoxyisobutyrate (Clofibrate) reaching almost 100%. After dosage with the combination preparation, the maximum blood level of clofibric acid was achieved after 2 hours, in contrast to 4 hours for Clofibrate. No accumulation of clofibric acid in the blood was found after 60 days treatment with combination preparation at a daily dosage of 3 tablets. Urinary excretion of clofibric acid for both the combination drug and Clofibrate was 90% in 48 hours.
Similar articles
-
[Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].Arzneimittelforschung. 1979;29(10):1621-4. Arzneimittelforschung. 1979. PMID: 583231 German.
-
[The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].Med Welt. 1975 Apr 4;26(14):655-63. Med Welt. 1975. PMID: 1099394 Clinical Trial. German. No abstract available.
-
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].Med Klin. 1978 Feb 17;73(7):231-9. Med Klin. 1978. PMID: 203832 Clinical Trial. German.
-
Clinical pharmacology and pharmacokinetics of nicotinic acid.Drug Metab Rev. 1979;9(1):99-106. Drug Metab Rev. 1979. PMID: 376259 Review.
-
Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.Drug Metab Rev. 1980;11(2):291-323. doi: 10.3109/03602538008994028. Drug Metab Rev. 1980. PMID: 7011761 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources